Minority interests and associates in LBO

Hey,

I have a 3 h LBO case study coming up. Lets say we are acquiring a company with non-controlling interests on its balance sheet as well as associates (we acquire 100%). 

Question 1: Since we acquire 100%, we must take out minority shareholders and thus include minority interest in our equity-to-EV bridge. We then adjust our balance sheet to remove minority interest. Correct?

Question 2: How would you handle associates? One alternative is to assume it is sold before close and thus included in cash and cash equivalents. The other alternative would be to included it in our Uses part of the S&U as it is not included in EV (it is subtracted when going from equity to EV). We would then remove it from balance sheet. Which alternative would you go for?

Question 3: Would a "better" option be to ignore these two items completely in the case study?

11 Comments
 

I am always in the camp of just make it clear. 

The thing I like about including it in the sources and uses is if it was in the original balance sheet you can map to it being removed.

But you can also just footnote it, just be consistent clear, and able to communicate what you did and you will be fine. 

 

Q1: a NCI is a minority shareholder in a subsidiary, so you can buy 100% of holding and not own the NCI shares. Make sure to value the NCI separatly as book value is not an appropiate proxy of its value often.

Q2: privately owned associates are not all of a sudden sold at book value, so no. In general you acquire them with the company so you have to fund them. They require a separate valuation too. Alternatives are to be negotiated with seller. So value of associates is a use of cash, so you need a source to fund it.

Q3: no.

 
Most Helpful

Rover-S

Q1: a NCI is a minority shareholder in a subsidiary, so you can buy 100% of holding and not own the NCI shares. Make sure to value the NCI separatly as book value is not an appropiate proxy of its value often.

Q2: privately owned associates are not all of a sudden sold at book value, so no. In general you acquire them with the company so you have to fund them. They require a separate valuation too. Alternatives are to be negotiated with seller. So value of associates is a use of cash, so you need a source to fund it.

Q3: no.

Q1. I guess you are right. How to reflect this in the S&U if the minority shareholders wish to remain in the biz vs sell their stake to the PE firm as well? If they wish to remain minority holders, would you simply add it under "Uses" as a "roll-over" item similar to how a management stake is rolled-over? And if they are exiting I guess you would just include it as a Use of cash (it is included in EV)?

 

monkey123456789

Rover-S

Q1: a NCI is a minority shareholder in a subsidiary, so you can buy 100% of holding and not own the NCI shares. Make sure to value the NCI separatly as book value is not an appropiate proxy of its value often.

Q2: privately owned associates are not all of a sudden sold at book value, so no. In general you acquire them with the company so you have to fund them. They require a separate valuation too. Alternatives are to be negotiated with seller. So value of associates is a use of cash, so you need a source to fund it.

Q3: no.

Q1. I guess you are right. How to reflect this in the S&U if the minority shareholders wish to remain in the biz vs sell their stake to the PE firm as well? If they wish to remain minority holders, would you simply add it under "Uses" as a "roll-over" item similar to how a management stake is rolled-over? And if they are exiting I guess you would just include it as a Use of cash (it is included in EV)?

Okay so if we were to show the EV in the uses, would you add owned associates to the uses side in the S&U table? Because it would not be accounted for if calculating with EV, since it gets excluded in the bridge, going from equity value to enterprise value.

 

Autem voluptatibus debitis enim veritatis officiis. Molestiae omnis labore nesciunt et iusto ut. Quasi et aspernatur pariatur dolores quam dolor minima. Esse maxime dolor similique optio.

Alias molestiae ullam consequatur ea explicabo omnis quis. Saepe eaque veritatis eveniet amet nostrum dolorem ut. Voluptatum odio harum non voluptates aliquid officia est. Exercitationem reiciendis non expedita consectetur. Facere sapiente tempora architecto.

Career Advancement Opportunities

June 2026 Private Equity

  • The Riverside Company 99.6%
  • Blackstone Group 99.3%
  • KKR (Kohlberg Kravis Roberts) 98.9%
  • Warburg Pincus 98.5%
  • Vista Equity Partners 98.1%

Overall Employee Satisfaction

June 2026 Private Equity

  • Blackstone Group 99.6%
  • KKR (Kohlberg Kravis Roberts) 99.2%
  • The Riverside Company 98.9%
  • Ardian 98.5%
  • Starwood Capital Group 98.1%

Professional Growth Opportunities

June 2026 Private Equity

  • Bain Capital 99.6%
  • The Riverside Company 99.3%
  • Blackstone Group 98.9%
  • Starwood Capital Group 98.5%
  • Vista Equity Partners 98.1%

Total Avg Compensation

June 2026 Private Equity

  • Principal (9) $653
  • Director/MD (24) $547
  • Vice President (98) $365
  • 3rd+ Year Associate (104) $281
  • 2nd Year Associate (235) $272
  • 1st Year Associate (411) $229
  • 3rd+ Year Analyst (33) $157
  • 2nd Year Analyst (97) $134
  • 1st Year Analyst (272) $124
  • Intern/Summer Associate (38) $81
  • Intern/Summer Analyst (355) $62
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
dosk17's picture
dosk17
98.9
7
DrApeman's picture
DrApeman
98.9
8
GameTheory's picture
GameTheory
98.9
9
CompBanker's picture
CompBanker
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”